Drug delivery systems for treatment of temporomandibular joint osteoarthritis

The number of people suffering from temporomandibular joint osteoarthritis (TMJOA) has been increasing. TMJOA cause joint noise, pain on TMJ and/or masticatory muscles, and restricted mandibular movement, which disturb eating, laughing and conversation, and impose serious lifestyle impediments. Chon...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2022-11, Vol.13, p.1054703-1054703
Main Authors: Huang, Xinqi, Pan, Xuefeng, Xiong, Xiner, Zhao, Zhihe, Cen, Xiao
Format: Article
Language:English
Subjects:
drug delivery
intra-articular injection
osteoarthritis
Pharmacology
temporomandibular joint
transdermal administration
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c445t-b90cba4a60f5242bc68f18bc6948fb82fe72f2627f77032caa70f06037b053a73
cites cdi_FETCH-LOGICAL-c445t-b90cba4a60f5242bc68f18bc6948fb82fe72f2627f77032caa70f06037b053a73
container_end_page 1054703
container_issue
container_start_page 1054703
container_title Frontiers in pharmacology
container_volume 13
creator Huang, Xinqi
Pan, Xuefeng
Xiong, Xiner
Zhao, Zhihe
Cen, Xiao
description The number of people suffering from temporomandibular joint osteoarthritis (TMJOA) has been increasing. TMJOA cause joint noise, pain on TMJ and/or masticatory muscles, and restricted mandibular movement, which disturb eating, laughing and conversation, and impose serious lifestyle impediments. Chondrocyte apoptosis, extracellular matrix degradation, synovitis, and subchondral bone remodeling are the main pathological features of TMJOA. Various drug delivery systems are developed to controlled release at specific activation sites with high bioactivity and inhibit rapid dilution to enable long-term therapeutic response, which present great potential for the treatment of TMJOA. This review focuses on recently developed drug delivery systems by different administration in the TMJOA treatment, and summarizes their effects, duration, safety, and limitations, which would pave the way for development of TMJOA therapy.
doi_str_mv 10.3389/fphar.2022.1054703
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ef0492a7d96f4a9996db384a1a786144</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ef0492a7d96f4a9996db384a1a786144</doaj_id><sourcerecordid>2739742772</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-b90cba4a60f5242bc68f18bc6948fb82fe72f2627f77032caa70f06037b053a73</originalsourceid><addsrcrecordid>eNpVkU1rwzAMhs3YYKXrH9gpx13SObZjx5fB6D6hY5ftbJTEbl2SOLOTQv_93A_GqouE9PJI4kXoNsNzSgt5b_o1-DnBhMwznDOB6QWaZJzTVBYZufxXX6NZCBscg0pJOZugjyc_rpJaN3ar_S4JuzDoNiTG-WTwGoZWd0PiTBK7vfOuha625diATzbO7kdR78APa28HG27QlYEm6NkpT9H3y_PX4i1dfr6-Lx6XacVYPqSlxFUJDDg2OWGkrHhhsiImyQpTFsRoQQzhRBgRnyEVgMAGc0xFiXMKgk7R-5FbO9io3tsW_E45sOrQcH6l4k22arTSBjNJQNSSGwZSSl6XtGCQgSh4xlhkPRxZ_Vi2uq7iwx6aM-j5pLNrtXJbJbngLKcRcHcCePcz6jCo1oZKNw102o1BEUGlYEQIEqXkKK28C8Fr87cmw2rvpTp4qfZeqpOX9BczKJUw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2739742772</pqid></control><display><type>article</type><title>Drug delivery systems for treatment of temporomandibular joint osteoarthritis</title><source>Open Access: PubMed Central</source><creator>Huang, Xinqi ; Pan, Xuefeng ; Xiong, Xiner ; Zhao, Zhihe ; Cen, Xiao</creator><creatorcontrib>Huang, Xinqi ; Pan, Xuefeng ; Xiong, Xiner ; Zhao, Zhihe ; Cen, Xiao</creatorcontrib><description>The number of people suffering from temporomandibular joint osteoarthritis (TMJOA) has been increasing. TMJOA cause joint noise, pain on TMJ and/or masticatory muscles, and restricted mandibular movement, which disturb eating, laughing and conversation, and impose serious lifestyle impediments. Chondrocyte apoptosis, extracellular matrix degradation, synovitis, and subchondral bone remodeling are the main pathological features of TMJOA. Various drug delivery systems are developed to controlled release at specific activation sites with high bioactivity and inhibit rapid dilution to enable long-term therapeutic response, which present great potential for the treatment of TMJOA. This review focuses on recently developed drug delivery systems by different administration in the TMJOA treatment, and summarizes their effects, duration, safety, and limitations, which would pave the way for development of TMJOA therapy.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2022.1054703</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>drug delivery ; intra-articular injection ; osteoarthritis ; Pharmacology ; temporomandibular joint ; transdermal administration</subject><ispartof>Frontiers in pharmacology, 2022-11, Vol.13, p.1054703-1054703</ispartof><rights>Copyright © 2022 Huang, Pan, Xiong, Zhao and Cen. 2022 Huang, Pan, Xiong, Zhao and Cen</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-b90cba4a60f5242bc68f18bc6948fb82fe72f2627f77032caa70f06037b053a73</citedby><cites>FETCH-LOGICAL-c445t-b90cba4a60f5242bc68f18bc6948fb82fe72f2627f77032caa70f06037b053a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676453/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676453/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Huang, Xinqi</creatorcontrib><creatorcontrib>Pan, Xuefeng</creatorcontrib><creatorcontrib>Xiong, Xiner</creatorcontrib><creatorcontrib>Zhao, Zhihe</creatorcontrib><creatorcontrib>Cen, Xiao</creatorcontrib><title>Drug delivery systems for treatment of temporomandibular joint osteoarthritis</title><title>Frontiers in pharmacology</title><description>The number of people suffering from temporomandibular joint osteoarthritis (TMJOA) has been increasing. TMJOA cause joint noise, pain on TMJ and/or masticatory muscles, and restricted mandibular movement, which disturb eating, laughing and conversation, and impose serious lifestyle impediments. Chondrocyte apoptosis, extracellular matrix degradation, synovitis, and subchondral bone remodeling are the main pathological features of TMJOA. Various drug delivery systems are developed to controlled release at specific activation sites with high bioactivity and inhibit rapid dilution to enable long-term therapeutic response, which present great potential for the treatment of TMJOA. This review focuses on recently developed drug delivery systems by different administration in the TMJOA treatment, and summarizes their effects, duration, safety, and limitations, which would pave the way for development of TMJOA therapy.</description><subject>drug delivery</subject><subject>intra-articular injection</subject><subject>osteoarthritis</subject><subject>Pharmacology</subject><subject>temporomandibular joint</subject><subject>transdermal administration</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1rwzAMhs3YYKXrH9gpx13SObZjx5fB6D6hY5ftbJTEbl2SOLOTQv_93A_GqouE9PJI4kXoNsNzSgt5b_o1-DnBhMwznDOB6QWaZJzTVBYZufxXX6NZCBscg0pJOZugjyc_rpJaN3ar_S4JuzDoNiTG-WTwGoZWd0PiTBK7vfOuha625diATzbO7kdR78APa28HG27QlYEm6NkpT9H3y_PX4i1dfr6-Lx6XacVYPqSlxFUJDDg2OWGkrHhhsiImyQpTFsRoQQzhRBgRnyEVgMAGc0xFiXMKgk7R-5FbO9io3tsW_E45sOrQcH6l4k22arTSBjNJQNSSGwZSSl6XtGCQgSh4xlhkPRxZ_Vi2uq7iwx6aM-j5pLNrtXJbJbngLKcRcHcCePcz6jCo1oZKNw102o1BEUGlYEQIEqXkKK28C8Fr87cmw2rvpTp4qfZeqpOX9BczKJUw</recordid><startdate>20221107</startdate><enddate>20221107</enddate><creator>Huang, Xinqi</creator><creator>Pan, Xuefeng</creator><creator>Xiong, Xiner</creator><creator>Zhao, Zhihe</creator><creator>Cen, Xiao</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20221107</creationdate><title>Drug delivery systems for treatment of temporomandibular joint osteoarthritis</title><author>Huang, Xinqi ; Pan, Xuefeng ; Xiong, Xiner ; Zhao, Zhihe ; Cen, Xiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-b90cba4a60f5242bc68f18bc6948fb82fe72f2627f77032caa70f06037b053a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>drug delivery</topic><topic>intra-articular injection</topic><topic>osteoarthritis</topic><topic>Pharmacology</topic><topic>temporomandibular joint</topic><topic>transdermal administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Xinqi</creatorcontrib><creatorcontrib>Pan, Xuefeng</creatorcontrib><creatorcontrib>Xiong, Xiner</creatorcontrib><creatorcontrib>Zhao, Zhihe</creatorcontrib><creatorcontrib>Cen, Xiao</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Xinqi</au><au>Pan, Xuefeng</au><au>Xiong, Xiner</au><au>Zhao, Zhihe</au><au>Cen, Xiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug delivery systems for treatment of temporomandibular joint osteoarthritis</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2022-11-07</date><risdate>2022</risdate><volume>13</volume><spage>1054703</spage><epage>1054703</epage><pages>1054703-1054703</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>The number of people suffering from temporomandibular joint osteoarthritis (TMJOA) has been increasing. TMJOA cause joint noise, pain on TMJ and/or masticatory muscles, and restricted mandibular movement, which disturb eating, laughing and conversation, and impose serious lifestyle impediments. Chondrocyte apoptosis, extracellular matrix degradation, synovitis, and subchondral bone remodeling are the main pathological features of TMJOA. Various drug delivery systems are developed to controlled release at specific activation sites with high bioactivity and inhibit rapid dilution to enable long-term therapeutic response, which present great potential for the treatment of TMJOA. This review focuses on recently developed drug delivery systems by different administration in the TMJOA treatment, and summarizes their effects, duration, safety, and limitations, which would pave the way for development of TMJOA therapy.</abstract><pub>Frontiers Media S.A</pub><doi>10.3389/fphar.2022.1054703</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2022-11, Vol.13, p.1054703-1054703
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ef0492a7d96f4a9996db384a1a786144
source Open Access: PubMed Central
subjects drug delivery
intra-articular injection
osteoarthritis
Pharmacology
temporomandibular joint
transdermal administration
title Drug delivery systems for treatment of temporomandibular joint osteoarthritis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A13%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20delivery%20systems%20for%20treatment%20of%20temporomandibular%20joint%20osteoarthritis&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Huang,%20Xinqi&rft.date=2022-11-07&rft.volume=13&rft.spage=1054703&rft.epage=1054703&rft.pages=1054703-1054703&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2022.1054703&rft_dat=%3Cproquest_doaj_%3E2739742772%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-b90cba4a60f5242bc68f18bc6948fb82fe72f2627f77032caa70f06037b053a73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2739742772&rft_id=info:pmid/&rfr_iscdi=true